wjz-13 all-news-99-1-wnew 1057-the-fan 1300logo2_67x35

Local

Carlyle Group Funds Fight Of Lou Gehrig’s Disease

View Comments
(Photo by Ron Sachs-Pool/Getty Images)

(Photo by Ron Sachs-Pool/Getty Images)

CBS Baltimore (con't)

Affordable Care Act Updates:
CBSBaltimore.com/ACA

Health News & Information:
CBSBaltimore.com/Health

WASHINGTON (AP) — Bloomberg LP CEO Daniel Doctoroff is joining with New York City Mayor Michael Bloomberg and David Rubenstein of Washington-based private equity firm The Carlyle Group to fund a $25 million initiative for treatment of Lou Gehrig’s disease.

They announced the three-year initiative called Target ALS on Thursday to provide a new system for sharing and coordinating findings among researchers. It will be managed by researchers at Columbia University Medical Center.

Target ALS is the next phase of a research initiative of New York-based Project A.L.S. and the Packard Center for ALS Research at Johns Hopkins University in Baltimore.

Researchers say the short-term goal is to facilitate drug-development programs at pharmaceutical and biotech companies. The longer-term goal is to find effective therapies for the disease.

(Copyright 2013 by The Associated Press. All Rights Reserved.)

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 3,175 other followers